Australian and international studies have shown the benefits pharmacists can make to direct patient care and better medication management.4,5 In the UK and New Zealand, reviews of medicine use have contributed to professional integration and patient care.6,7 In Canada, early concerns about collaborative practice have been resolved as general practitioners discovered the benefits of working with pharmacists.8,9 General practitioners are more likely to accept a pharmacist's recommendations if they have personal contact in case conferences than they are if they are sent written recommendations.10 General practitioners may be reluctant to use a service led by a pharmacist who they do not personally know.11
The TEAMCare coordinated care trial demonstrated that pharmacists and general practitioners can work together in a primary care environment, although a greater degree of trust and collaboration is required.12Trust appears to grow over time. When pharmacists are co-located with general practitioners there is a greater opportunity for trust to develop.13 However, the full effect of pharmacist integration may take longer than one year to perceive clearly.14
Studies that have integrated pharmacists into primary care practices have shown improved patient outcomes.15 Collaborative models have improved the treatment of hypertension.16 Pharmacists have the potential to optimise drug therapy by identifying medication-therapy problems and recommending solutions.17 Prescribers are receptive to such recommendations.18 Pharmacist–patient consultations in relation to medication management within general practitioners' surgeries and in patients' homes have high acceptability to patients.19
A role for a pharmacist within a general practice has been proposed to provide multiple risk management strategies to improve medication safety. The role would focus on interventions to high-risk patient groups and disease states, and would use practice information technology systems to detect potential safety problems.20
Interdisciplinary teaching of pharmacotherapeutics provides health professionals with greater insight into their respective roles. This could improve the quality use of medicines and reduce medication errors.21
Medication reviews
Medication reviews show the benefits of cooperation. Government remuneration for medication reviews by pharmacists began in 1997 in residential aged care facilities and in 2001 for community patients. Collaborative medication reviews are included in many general practitioner and pharmacist practices, clinical practice guidelines and decision support tools. Several randomised trials have shown improvements in prescribing, and reduced healthcare use and medication costs following medication reviews in patients with hypertension, hyperlipidaemia and diabetes.22-4
The evidence supporting the benefits of home medicines reviews continues to expand. They can be effective in delaying the time to next hospitalisation for heart failure,25identifying drug-related problems among people receiving treatment for mental illnesses,26and assisting in the resolution of medication-related problems.27Medication reviews after discharge from hospital have reduced morbidity and mortality in patients with heart failure.28
Despite this evidence and considerable support by the Pharmacy Guild and Divisions of General Practice, home medicine reviews are still underused. For example, they are not used enough in the detection and prevention of medication-related problems in cardiovascular disease.29